Karimeldin Awad

Karimeldin Awad practices at Baycare Medical Group, Inc. in Saint Petersburg, Florida.

Karimeldin Awad's NPI, 1245718923, was assigned on August 3, 2018. Karimeldin Awad holds Florida license ME1502033.

Karimeldin Awad's primary practice is Baycare Medical Group, Inc., at 620 10th N St, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 281-9065.

Karimeldin Awad's primary practice is Baycare Medical Group, Inc. in Saint Petersburg, Florida. Karimeldin Awad is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is BayCare Medical Group. Dmand AI also links Karimeldin Awad to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karimeldin Awad practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Karimeldin Awad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Karimeldin Awad is licensed in Florida.

CMS data shows 230 Medicare services from Karimeldin Awad across 3 procedure codes in 2024, for 93 Medicare patients. Medicare paid $21,213 for them. Every service was in an office.

CMS counts 93 Medicare patients who saw Karimeldin Awad in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Karimeldin Awad's median patient age at 59, with 44% women.

In 2024, Karimeldin Awad wrote 2,594 Medicare Part D claims for 189 patients. 87% of them were for generic drugs. CMS names the drug for 1,991 of them, across 44 drugs with 11 or more claims each, at $171,250 in total drug cost. In 2023, CMS named 1,236 claims across 36 drugs.

Karimeldin Awad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karimeldin Awad as offering telehealth.

CMS Open Payments shows 188 general payments to Karimeldin Awad from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $804.